Co-Marketing Agreements

News Co-Marketing Agreements

• Qlucore targets academic and commercial biotech, life science markets with Novo Newton

  Qlucore has announced an agency agreement with Novo Newton Scientific Ltd. Novo Newton will assist in marketing Qlucore's Omics Explorer software in Ireland, Spain, Italy and South Africa. Recently Qlucore has also signed a distribution agreement in Japan, and raised investment finance for expansion more

• Agilent Technologies and Sage Science Sign Agreement to Comarket Bioanalyzer and Pippin Prep DNA Systems

  Agilent Technologies Inc. and Sage Science Inc. announced that they have signed a comarketing agreement involving Agilent’s 2100 Bioanalyzer, used for the detection and quantification of nucleic acids, and Sage’s Pippin Prep DNAsize-selection system.The agreement between Sage and Agilent includes th more

• iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. announce collaborative agreement to offer a combined service offering

  iThemba Pharmaceuticals’ service division and Pyxis Discovery announced that they have signed a collaborative agreement to jointly market both companies’ services. Pyxis’s computational chemistry and lead discovery expertise will be coupled with iThemba’s service division to provide medicinal and more

Market studies Co-Marketing Agreements

• Strides Arcolab Limited (532531) - Financial and Strategic SWOT Analysis Review

  Strides Arcolab Limited (Strides Arcolab) is an Indian pharmaceutical company, engaged in the manufacturing and export of finished branded and generic drugs. The company principally offers gelatin capsules and sterile parenterals. It offers products for the treatment of malaria, immune deficiency sy more

• Sosei Co. Ltd. (4565) - Financial and Strategic SWOT Analysis Review

  Sosei Co. Ltd., (Sosei)is a privately held company that is engaged in the process of drug development. The product pipeline of the company is supplemented by in-licensing agreements for compounds from Western and Japanese companies. The research programmes developed by the company usually referred a more

• Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic SWOT Analysis Review

  Nang Kuang Pharmaceutical Co., Ltd. (Nang Kuang) is focused on the manufacture, processing and trading of western medicines. The company’s major products include small volume parenterals (SVP), large volume parenterals (LVP), central nervous system medicines, allergic medicines and circulatory syste more

Websites Co-Marketing Agreements